| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 7.372 | 19.686 | 30.749 | 52.970 | 41.858 | 22.132 | 19.185 | 16.351 | 25.251 | 26.157 |
| Total Income - EUR | 7.372 | 22.290 | 30.935 | 52.933 | 41.858 | 22.934 | 19.185 | 16.351 | 25.251 | 26.158 |
| Total Expenses - EUR | 18.096 | 25.691 | 34.574 | 43.434 | 31.300 | 12.442 | 13.927 | 4.341 | 22.983 | 21.768 |
| Gross Profit/Loss - EUR | -10.724 | -3.401 | -3.640 | 9.500 | 10.558 | 10.492 | 5.258 | 12.010 | 2.269 | 4.389 |
| Net Profit/Loss - EUR | -10.928 | -4.034 | -4.964 | 8.970 | 10.126 | 10.091 | 4.682 | 11.358 | 1.926 | 3.694 |
| Employees | 2 | 2 | 2 | 2 | 1 | 1 | 1 | 1 | 1 | 1 |
Check the financial reports for the company - Sensident Med Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 36.763 | 61.962 | 49.369 | 37.147 | 26.787 | 23.470 | 20.445 | 29.100 | 25.500 | 25.297 |
| Current Assets | 7.429 | 6.532 | 9.865 | 6.705 | 6.840 | 14.939 | 12.129 | 24.586 | 22.099 | 17.574 |
| Inventories | 3.115 | 3.803 | 5.128 | 2.982 | 4.568 | 10.214 | 9.825 | 20.988 | 16.394 | 14.189 |
| Receivables | 1.215 | -1.275 | 1.135 | 1.009 | 1.095 | 2.238 | 397 | 798 | 797 | 440 |
| Cash | 3.098 | 4.004 | 3.601 | 2.713 | 1.177 | 2.487 | 1.907 | 2.800 | 4.908 | 2.945 |
| Shareholders Funds | -33.597 | -37.288 | -41.621 | -31.887 | -21.143 | -10.652 | -5.734 | 5.607 | 7.515 | 11.167 |
| Social Capital | 225 | 223 | 219 | 215 | 211 | 207 | 202 | 203 | 202 | 201 |
| Debts | 77.789 | 104.762 | 100.855 | 75.738 | 54.799 | 49.061 | 38.308 | 48.108 | 40.262 | 31.843 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8623 - 8623" | |||||||||
| CAEN Financial Year |
8623
|
|||||||||
Comments - Sensident Med Srl